Universe Pharmaceuticals INC Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure
Universe Pharmaceuticals INC (UPC) reported Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure of $70.23 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Notes
us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure · last filed 2026-01-29
| Period end | Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure 12 month |
|---|---|
| 2025-09-30 | $70.23M 20-F · filed 2026-01-29 |